Y. U. Ates Et Al. , "The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer," Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Vienna, Austria, 2023
Ates, Y. U. Et Al. 2023. The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer. Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (Vienna, Austria).
Ates, Y. U., Aydos, U., Balcı, E., & Atay, L. Ö., (2023). The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer . Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria
Ates, Y. Et Al. "The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer," Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, Austria, 2023
Ates, Y. U. Et Al. "The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer." Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Vienna, Austria, 2023
Ates, Y. U. Et Al. (2023) . "The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer." Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , Vienna, Austria.
@conferencepaper{conferencepaper, author={Y. Unluer Ates Et Al. }, title={The Role of Primary Tumor PET/MR Quantitative Values in Predicting Pathological Complete Response after Neoadjuvant Treatment in Breast Cancer}, congress name={Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={Vienna}, country={Austria}, year={2023}}